ARAN - Access to Research at NUI Galway

On the validity of setting breakpoint minimum inhibition concentrations at one quarter of the plasma concentration achieved following oral administration of oxytetracycline

ARAN - Access to Research at NUI Galway

Show simple item record

dc.contributor.author Pursell, Lisa
dc.contributor.author Smith, Peter
dc.date.accessioned 2011-11-11T16:28:31Z
dc.date.available 2011-11-11T16:28:31Z
dc.date.issued 2004-05-31
dc.identifier.citation Coyne, R., Samuelsen, O., Bergh, O., Andersen, K., Pursell, L., Dalsgaard, I., et al. (2004). On the validity of setting breakpoint minimum inhibition concentrations at one quarter of the plasma concentration achieved following oral administration of oxytetracycline. Aquaculture, 239(1-4), 23-35. en_US
dc.identifier.uri http://hdl.handle.net/10379/2314
dc.description.abstract Plasma concentrations of oxytetracycline (OTC) were established in two Atlantic salmon (Salmo salar) pre-smolts populations after they had received OTC medicated feed at a rate of 75 mg OTC/kg over 10 days. One population was experiencing an epizootic of furunculosis in a commercial freshwater farm and the other was held in a laboratory. Both populations were maintained at approximately 13 jC. The mean plasma concentration in 26 health farm fish was 0.25F0.06 and the 80th percentile was 0.21 mg/l. The mean concentration for 26 laboratory fish was 0.21F0.06 mg/l with an 80th percentile of 0.15 mg/l. The validity of setting a breakpoint minimum inhibitory concentration (MIC) at a quarter of these plasma concentrations was investigated. The MIC of the Aeromonas salmonicida isolated from the farmed fish (n = 7) was 0.5 mg/l and the breakpoints generated by application of the 4:1 ratio were in the range 0.03125 - 0.0625 mg/l. These breakpoint values would, therefore, predict that the therapy should have had no beneficial effect and that any strain of A. salmonicida with MIC>0.0625 mg/l must be considered as resistant. A consideration of the pattern of the mortalities before and during the period of therapy suggests that the therapy was probably beneficial. Thus, the data obtained in this work suggest that the application of the 4:1 ratio is not a valid method of generating meaningful breakpoint MIC values. en_US
dc.format application/pdf en_US
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.subject Oxytetracycline therapy en_US
dc.subject Breakpoints en_US
dc.subject Minimum inhibitory concentrations en_US
dc.subject Plasma concentrations en_US
dc.subject Health Promotion en_US
dc.title On the validity of setting breakpoint minimum inhibition concentrations at one quarter of the plasma concentration achieved following oral administration of oxytetracycline en_US
dc.type Article en_US
dc.local.publishedsource http://dx.doi.org/10.1016/j.aquaculture.2004.05.036 en_US
dc.description.peer-reviewed peer-reviewed en_US
dc.contributor.funder Marie Curie Fellowship (QLK2-CT-2000-51162) en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record